Product Code: BHD0957SA
"India Telemedicine Market to Reach Rs. 1,765.5 Crore by 2025."
Market Report Coverage - India Telemedicine
Market Segmentation
- Products and Services (Services, Hardware, and Software)
- Hardware Sub-Segmented into Communication and Networking Equipment, Medical Equipment, and Others (Carts, Kits, etc.)
- Specialty (Radiology, General Practices, Psychiatry & Mental Health, Cardiology & Metabolic Disorders, Oncology, Gynecology, and Other Specialties)
Regional Segmentation
- Urban India (Tier I Cities, Tier II Cities, Tier III Cities, and Tier IV & V Cities)
Growth Drivers
- Increasing Support from Government of India
- Implementation of Social Distancing Norms and WFH Rules
- Increasing Internet-User Base in Urban and Rural Areas
- Increasing Interest from Doctors and Hospital
Market Challenges
- Issues with Data Privacy
- Lack of Awareness Among Rural Population
- Infrastructural Challenges
Market Opportunities
- Leverage the COVID-19 Phase to Ramp-Up Telemedicine Infrastructure, Especially in States with High Growth Opportunity
- Setting-Up a Complete Integrated Solution Across India
Key Companies Profiled
Lybrate, mFine, vHealth, Zoylo Digihealth Pvt. Ltd., TeleVital, 1Mg, M16 Labs, Artem Health, Netmeds, Tattvan, and Medimetry.
Key Questions Answered in this Report:
- What are the key regulations governing telemedicine services in India?
- How is the expansion of telemedicine expected to impact India's health system?
- What are the key technologies that can be implemented in the telemedicine ecosystem in India?
- How has the COVID-19 pandemic impacted India's telemedicine landscape?
- Who are the leading players that hold significant dominance in the India telemedicine market, currently?
- What are the key business and delivery models followed by telemedicine service providers in India and across the world?
- What are the key market drivers, challenges, growth opportunities, and trends?
- Which are the most lucrative states for the growth of telemedicine services in India?
- How is the expiration of patents likely to disrupt market dynamics?
- Who are the collaborative bodies aimed at propagating telemedicine across India?
- What are the key strategies incorporated by the leading players in the market?
- What is the likelihood of new players entering the market in the near term?
- What is the current revenue contribution for the urban and rural areas in the country, and how is it expected to change in the coming years?
- What is the return-on-investment and break-even timeline for different levels of telemedicine set-up?
- What are the emerging applications of telemedicine in India?
Key USPs of the Report
Following are some of the key contents of the report:
Impact of COVID-19
This chapter encompasses a description of the current state of the telemedicine market in India, as well as the changes observed as an effect of the lockdown and social distancing norms in the country. Several parameters have been considered, including the difference in levels of adoption in the pre- and post-COVID scenario, funding scenario, reimbursement, and regulatory landscape, and the possibility of an influx of new market entrants.
This chapter will enable the readers to understand the level of impact on the industry due to the COVID-19 pandemic.
Business Model Analysis
This chapter comprises the following information:
Revenue Channel Analysis
This section analyzes the different business models pursued by players and in India, which is concluded in a brief comparative analysis of the strong revenue channels for existing as well as new players.
Value Chain Analysis
This section describes in detail the value chain for telemedicine as a whole, i.e., including the service providers, healthcare providers, hardware and software providers, and telecommunications service providers. In addition, it also describes the value chain, specifically for telemedicine service providers.
Furthermore, the chapter also discusses the emerging areas of application for telemedicine in India, the digital readiness of different states, and the future opportunities, which could be untapped with the aid of strong government support.
Telemedicine Infrastructure Set-Up Cost Analysis
This section is useful to understand the amount of investment required for different levels of telemedicine setups. In addition, the chapter also provides ROI matrices and break-even analysis to analyze the profitability of the business.
Case Studies
This chapter assesses some of the key players based on their delivery and business models, collaborations, funding, offering, and operational & expansion strategies.
In addition, the report provides:
- A detailed analysis and growth forecast (2020-2025) for different market segments
- Recent developments and trends in India as well as the global market landscape
- Average consultation costs based on specialties
- Factors promoting and inhibiting market growth
Expert Quote
"The issue with low penetration of telemedicine in the rural areas of India is not due to lack of infrastructure. Infrastructure is sufficiently available. There is a lack of willingness among market participants to go there and expand."
Scope of the India Telemedicine Market
The report constitutes an in-depth analysis of the India telemedicine market, including a thorough analysis of the products and services. The study also presents detailed analysis and forecast for the India telemedicine services market by region and specialty. The report considers hardware, software, and services for estimating the overall telemedicine market size in India. However, market splits by region and specialties have been provided for consultation services.
The purpose of the study is to gain a holistic view of the telemedicine market in India in terms of various factors using it, including regulations, technology, end-user acceptance, and others. The study provides a plethora of information on several aspects, including market competition, business models, return on investment, set-up cost, consultation costs, and other vital information with respect to the India telemedicine market.
Table of Contents
1 Research Methodology
- 1.1 Product Definition
- 1.2 Primary Data Sources
- 1.3 Secondary Research
- 1.4 Data Triangulation
- 1.5 Data and Prediction Modeling
2 Global Telemedicine Market Overview
- 2.1 Global Market Size
- 2.2 Global Telemedicine Market, by Region
- 2.2.1 North America
- 2.2.2 Europe
- 2.2.3 Asia-Pacific
- 2.2.4 Rest-of-the-World
- 2.3 Recent Developments
- 2.3.1 Mergers and Acquisitions
- 2.3.2 Product Launches
- 2.3.3 Collaborations and Partnerships
- 2.3.4 Recent Funding Rounds
- 2.4 Telemedicine Implementation in Other Countries
- 2.4.1 China
- 2.4.2 Singapore
- 2.4.3 E.U. and the European Region
3 Impact of COVID-19 on the Telemedicine Market
- 3.1 Key Highlights on Pre- and Post-COVID-19 Scenario
- 3.1.1 Evolution of Telemedicine
- 3.1.2 Need for Telemedicine: A View of Changing Medical Practices
- 3.1.3 Level of Adoption from a Pre-and Post COVID Perspective
- 3.1.4 Impact on Telemedicine due to COVID Related Measures (Social Distancing and WFH)
- 3.1.5 Competitive Landscape: Existing and New Entrant competition analysis
- 3.1.6 Funding Scenario
- 3.1.7 Reimbursement and Regulatory Scenario
- 3.1.8 Impact of Telemedicine on Health Systems
4 India Telemedicine Market Overview Industry Insights
- 4.1 India Telemedicine Market
- 4.1.1 Market Size and Future Potential
- 4.1.2 Key Industry Participants
- 4.1.3 Telemedicine Consultation Volume
- 4.1.4 Technology Landscape - India Telemedicine Market
- 4.1.4.1 Attempts Made to Boost Telemedicine Adoption
- 4.1.4.1.1 North-East
- 4.1.4.1.2 Odisha
- 4.1.4.1.3 Bihar
- 4.1.4.1.4 Jharkhand
- 4.2 Recent Developments
- 4.2.1 Mergers and Acquisitions
- 4.2.2 Product Launches (New Offerings)
- 4.2.3 Collaborations and Partnerships
- 4.2.4 Recent Funding Rounds
- 4.3 Government Regulations
- 4.3.1 Infrastructure
- 4.3.2 Communication and Network
- 4.3.3 Data Security
- 4.3.4 Devices
- 4.3.5 Resources
- 4.4 Reimbursement Scenarios
- 4.5 Telemedicine Technology Landscape
- 4.5.1 Key Innovation and Developments
- 4.5.1.1 Cloud-Based Platforms
- 4.5.1.2 The Use of Artificial Intelligence and Machine Learning
- 4.5.1.3 E-Clinics
- 4.5.1.4 Remote Monitoring
- 4.5.2 Technology Providers
- 4.5.2.1 Data Collection, Storage, and Retrieval Platforms
- 4.5.2.2 Video Conferencing and Connected Care Platforms
- 4.5.2.3 Smart Telemedicine Platforms (Integration)
- 4.5.2.4 Connected Medical Devices
- 4.6 Telemedicine Supporting Organizations and Associations in India
- 4.6.1 Indian Space Research Organization (ISRO)
- 4.6.2 Telemedicine Society of India (TSI)
- 4.6.3 Digital Health India Association (DHIndia)
- 4.6.4 Centre for Development of Advanced Computing (CDAC)
5 Market Dynamics
- 5.1 Growth Promoting Factors
- 5.1.1 Increasing Support from the Government of India
- 5.1.2 Implementation of Work-From-Home and Social Distancing Norms
- 5.1.3 Increasing Internet User Base in Urban and Rural Areas
- 5.1.4 Increasing Interest from Doctors and Hospitals
- 5.2 Market Challenges
- 5.2.1 Data Privacy
- 5.2.2 Lack of Awareness Among Rural Population
- 5.2.3 Infrastructural Challenges
- 5.3 Market Opportunities
- 5.3.1 Leverage the COVID-19 Phase to Ramp-Up Telemedicine Infrastructure, Especially in States with High Growth Opportunity
- 5.3.2 Setting-Up a Complete Integrated Solution Across India
- 5.4 Market Trends
- 5.4.1 Healthcare IT
- 5.4.2 Patient Monitoring with Telepresence Robots
- 5.4.3 Intelligent Diagnostics
- 5.4.4 Health 4.0: Information Exchange and Collaboration
6 India Telemedicine Market by Product and Services, 2020-2025
- 6.1 Hardware
- 6.1.1 Communication and Networking
- 6.1.2 Medical Devices
- 6.1.3 Other Devices (Telemedicine Cart, PAT, Kits, etc.)
- 6.2 Software
- 6.3 Telemedicine Consultation Services
7 India Telemedicine Market by Specialty, 2020-2025
- 7.1 Cardiology and Metabolic Disorders
- 7.2 Oncology
- 7.3 Psychiatry and Mental Health
- 7.4 Radiology
- 7.5 General Practices
- 7.6 Gynecology
- 7.7 Other Specialties
- 7.8 Market Value in Different States
8 India Telemedicine Market by Region, 2020-2025
- 8.1 Urban Telemedicine Market
- 8.1.1 Market Size and Growth Potential
- 8.1.2 Market Split by Specialty
- 8.1.3 Market Split, by City Type
- 8.1.4 Tier I Cities
- 8.1.5 Tier II Cities
- 8.1.6 Tier III Cities
- 8.1.7 Tier IV & V Cities
- 8.2 Rural
- 8.2.1 Market Size and Growth Potential
- 8.2.2 Market Size Split by Specialty
- 8.3 Market by States
9 India Telemedicine Market Competitive Landscape
- 9.1 Company Distribution
- 9.2 Market Share Analysis (Products and Consultation Services), 2018 & 2019
- 9.3 Growth Share Matrix, 2018 & 2019
- 9.3.1 Products
- 9.3.2 Consultation Services
10 India Telemedicine Business Model Analysis
- 10.1 Revenue Channel Analysis
- 10.2 Value Chain Analysis
- 10.3 Emerging Areas of Application
- 10.3.1 Use of Telemedicine Network for Tele-Education
- 10.3.2 School-Based Telemedicine E-Clinics
- 10.4 Future Opportunities
- 10.4.1 Building a Complete Digital Health Ecosystem in India for Seamless Care
- 10.4.2 Automating Parts of the Telemedicine Process
- 10.5 Readiness of Different States (In Terms of Digital Infrastructure)
11 Telemedicine Consultation Cost Analysis
- 11.1 General Physician Cost
- 11.2 Specialist Consultation
12 Telemedicine Infrastructure Set-up Cost Analysis
- 12.1 Basic Level
- 12.2 Mid-Level
- 12.3 Advanced Level
- 12.4 Return-on-Investment Analysis
- 12.4.1 ROI Timelines
- 12.4.1.1 Advanced Level Set-Up
- 12.4.1.2 Mid-Level Set-Up
- 12.4.1.3 Basic Level Set-Up
- 12.4.2 ROI Matrices
- 12.4.2.1 Advanced Level Set-Up
- 12.4.2.2 Mid-level Set-Up
- 12.4.2.3 Basic Level Set-Up
13 Case Studies (Global and India)
- 13.1 Teladoc
- 13.1.1 Overview
- 13.1.2 Business Model
- 13.1.3 Delivery Model
- 13.1.4 Collaborations and Partnerships
- 13.1.5 Funding and Financials
- 13.1.6 Products/Services Offerings
- 13.1.7 Operational and Expansion Strategies
- 13.2 iCliniq
- 13.2.1 Overview
- 13.2.2 Business Model
- 13.2.3 Delivery Model
- 13.2.4 Collaborations and Partnerships
- 13.2.5 Funding
- 13.2.6 Products/Services Offerings
- 13.2.7 Operational and Expansion Strategies
- 13.3 TeleVital
- 13.3.1 Overview
- 13.3.2 Business Model
- 13.3.3 Delivery Model
- 13.3.4 Collaborations and Partnerships
- 13.3.5 Funding
- 13.3.6 Products/Service Offerings
- 13.3.7 Operational and Expansion Strategies
- 13.4 MeMD
- 13.4.1 Overview
- 13.4.2 Business Model
- 13.4.3 Delivery Model
- 13.4.4 Collaborations and Partnerships
- 13.4.5 Funding
- 13.4.6 Products/Service Offerings
- 13.4.7 Operational and Expansion Strategies
- 13.5 mFine
- 13.5.1 Overview
- 13.5.2 Business Model
- 13.5.3 Delivery Model
- 13.5.4 Collaborations and Partnerships
- 13.5.5 Funding
- 13.5.6 Products/Service Offerings
- 13.5.7 Operational and Expansion Strategies
14 Company Profiles
- 14.1 Market Share Analysis
- 14.2 1mg
- 14.2.1 Business Overview
- 14.2.2 Offerings
- 14.2.3 Recent Developments
- 14.2.4 1mg: SWOT Analysis
- 14.3 CVS Health (vHealth by Aetna)
- 14.3.1 Business Overview
- 14.3.2 Offerings
- 14.3.3 Recent Developments
- 14.3.4 CVS Health (vHealth by Aetna): SWOT Analysis
- 14.4 Dhanush Healthcare Pvt. Ltd.
- 14.4.1 Business Overview
- 14.4.2 Offerings
- 14.4.3 Recent Developments
- 14.4.4 Dhanush Healthcare Pvt. Ltd.: SWOT Analysis
- 14.5 Lybrate
- 14.5.1 Business Overview
- 14.5.2 Offerings
- 14.5.3 Recent Developments
- 14.5.4 Lybrate: SWOT Analysis
- 14.6 M16 Labs
- 14.6.1 Business Overview
- 14.6.2 Offerings
- 14.6.3 M16 Labs: SWOT Analysis
- 14.7 MediMetry
- 14.7.1 Business Overview
- 14.7.2 Offerings
- 14.7.3 Recent Developments
- 14.7.4 MediMetry: SWOT Analysis
- 14.8 mFine
- 14.8.1 Business Overview
- 14.8.2 Offerings
- 14.8.3 Recent Developments
- 14.8.4 mFine: SWOT Analysis
- 14.9 Netdox Health (Onco.com)
- 14.9.1 Business Overview
- 14.9.2 Offerings
- 14.9.3 Recent Developments
- 14.9.4 Netdox Health (Onco.com): SWOT Analysis
- 14.10 Netmeds
- 14.10.1 Business Overview
- 14.10.2 Offerings
- 14.10.3 Recent Developments
- 14.10.4 Netmeds: SWOT Analysis
- 14.11 Practo
- 14.11.1 Business Overview
- 14.11.2 Offerings
- 14.11.3 Recent Developments
- 14.11.4 Practo: SWOT Analysis
- 14.12 Rijuven
- 14.12.1 Business Overview
- 14.12.2 Offerings
- 14.12.3 Recent Developments
- 14.12.4 Rijuven: SWOT Analysis
- 14.13 Tattvan E Clinics
- 14.13.1 Business Overview
- 14.13.2 Offerings
- 14.13.3 Recent Developments
- 14.13.4 Tattvan E Clinics: SWOT Analysis
- 14.14 TeleVital
- 14.14.1 Business Overview
- 14.14.2 Offerings
- 14.14.3 Recent Developments
- 14.14.4 TeleVital: SWOT Analysis
- 14.15 Zoylo Digithealth Pvt. Ltd.
- 14.15.1 Business Overview
- 14.15.2 Offerings
- 14.15.3 Recent Developments
- 14.15.4 Zoylo Digihealth Pvt. Ltd.: SWOT Analysis
比較リスト
